Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.1B | 19.3B | 19.9B | 18.6B |
Cost of revenue | 8.8B | 8.7B | 8.7B | 8.5B |
Gross profit | 11.3B | 10.6B | 11.2B | 10.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.1B | 3.9B | 3.9B | 3.7B |
Operating income | 3.3B | 2.8B | 3.4B | 2.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 675.6M | 451.5M | 364.3M | 352.7M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 2.8B | 2.6B | 2.3B |
Tax provision | 485.3M | 250.9M | 679.7M | 560.7M |
Net income | 1.9B | 2.5B | 1.9B | 1.7B |
Basic EPS | — | 3.3 | 2.3 | 2.2 |
Diluted EPS | — | 3.3 | 2.3 | 2.2 |
Basic average shares | — | 755.8M | 754.1M | 754.4M |
Diluted average shares | — | 755.8M | 754.1M | 754.4M |
EBITDA | 4.6B | 4.0B | 4.5B | 3.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -41.3M | -64M | -166.2M | -80.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |